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Performing Complete Superficial Vein Ablation in Pa-
tients with Obesity and Severe Chronic Venous Dis-
ease: Who Benefits?
Frank Vandy, Susan Blackburn, Jess Bloom, Amber Clay,
Elaine Fellows, Ken Guire, Michele Kantola, William La-
forge, Cathy Stabler, Nicole Baker, Emily Cummings, Lisa
Pavone, John Rectenwald, Thomas Wakefield. University
of Michigan, Ann Arbor, MI
Objectives: The relationship between CEAP class and
Venous Clinical Severity Score (VCSS) change following
great saphenous vein ablation (GSVa) is under reported.
We further defined this relationship in patients including
those with severe chronic venous disease (CVD) and the
obese.
Methods: We reviewed our prospectively collected ve-
nous procedural database from January 2007 to October
2010 for patients who had undergone GSVa ( phlebec-
tomies). A CEAP class 5 or 6 designated severe CVD.
VCSS were obtained preoperatively and at the 1st, 2nd, and
3rd follow up visits.
Table 1. Patient Demographics
CEAP 2 CEAP 3 CEAP 4
CEAP 5
and 6 p value
NUMBER OF
LIMBS 111 109 29 16 N/A
MALE:FEMALE 28:87 22:87 13:16 5:11 .036
MEAN AGE 49.67 52.49 54.79 53.19 .094
MEAN BMI 28.92 29.60 32.82 35.41 .01
RFA:EVLT 59:51 40:69 10:19 13:3 .001
PHLEBETOMIES
n(%) 66 (59%) 32 (29%) 8 (28%) 2 (13%) .001
BMI - Body Mass Index (kg/m2); RFA - Radiofrequency Ablation; EVLT -
Endovenous Laser Treatment
Results: 265 limbs in 216 patients underwent GSVa.
(Table 1) Follow up was done at a mean of 7.5, 102.7,
and 242.6 days postoperatively. A significant association
between CEAP class and a declining VCSS following
GSVa was seen, such that more severe CVD does not
improve to the same degree as less severe CVD.(Fig 1) A
direct correlation between increasing BMI and higher
VCSS by a coefficient of .053 was demonstrated. (p 
.001).
Conclusions: Although all groups improved, the de-
gree of improvement was influenced by BMI and CEAP
class. Realistic outcomes must be considered when coun-
seling patients.
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Results of an Aggressive Surveillance and Retrieval
Protocol for Inferior Vena Cava (IVC) Filter Removal
Elizabeth Blazick, Mounir J. Haurani, Virendra I. Patel,
Glenn M. LaMuraglia, Christopher J. Kwolek, Mark F.
Conrad. Massachusetts General Hospital, Boston, MA
Objectives: The use of retrievable IVC filters has
come under increased scrutiny due to concerns about
poor retrieval rates (often 20%) and the long-term risk
of fracture and embolization. This study details the
results of an aggressive protocol of follow-up and re-
trieval of IVC filters.
Methods: We identified all patients who had Bard G2
or G2X filters placed from 1/2006-4/2010. A registry was
established and patients were followed in the office and
counseled regarding filter removal. 76% (186/244) of pa-
tients underwent CT scanning prior to this visit to assess the
integrity of the filter and IVC patency.
Results: There were 244 patients in the study cohort
with amean follow-up of 461 days. 92 (38%) were placed in
the ICU using intravascular ultrasound. Filter indications
included: 148 (61%) thrombotic event with a contraindica-
tion to anticoagulation, 9 (4%) failure of medical therapy
and 87 (35%) prophylaxis. 100 (41%) patients had a deep
venous thrombosis (DVT) at the time of placement and 73
(30%) had pulmonary emboli (PE). Follow-up was avail-
able on 228 (93%) patients. 69 (28%) patients died prior to
removal, the average time to death was 162 days with no
filter related deaths. Retrieval was attempted in 99/175
(57% of live patients) and successful in 94(95%); average
time to retrieval was 246 days (range 8-1548 days). The
remaining 76 (31%) filters were permanent: 31 due to
patient preference, 29 for clinical indication and 16 were
lost to follow-up. There was 1 (0.5%) filter fracture identi-
fied, 6 (3%) IVC occlusions, 30(16%) filters were tipped to
one side and 63 (34%) had some degree of penetration of
the IVC.
Conclusions: Through aggressive follow-up, 93% of
patients were evaluated for filter removal. Retrieval was suc-
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 17S Abstracts 13S
cessful in 95% of those attempted. An aggressive follow-up
protocol can double the retrieval rates previously reported
while the risk of fracture/embolization is1%when filters are
aggressively removed at a mean of 246 days.
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Caval Perforation by Retrievable IVC Filters and Con-
siderations for Open Explantation
Peter Connolly2, Vinod Balachandran1, Govind Nandaku-
mar1, David Trost1, Darren Schneider1, Harry L. Bush1.
1New York-Presbyterian Hospital, Weill Cornell Medical
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York, NY
Objectives: Retrievable inferior vena cava (IVC) filters
were introduced to provide protection from pulmonary
emboli (PE) in patients with short-term PE risk, with the
option to be removed once the PE risk subsides. However,
many filters are not removed and there are increasing
reports describing complications from retrievable filters
including IVC perforation, erosion into adjacent struc-
tures, migration, and filter fracture. Importantly, the fre-
quency of these complications is likely to increase as
greater numbers of IVC filters are being placed and we
describe our experience with open filter explantation for
IVC perforation.
Methods: We describe 5 cases of open filter explanta-
tion for IVC perforation by retrievable IVC filters following
unsuccessful endovascular retrieval.
Results: Five patients underwent successful laparot-
omy and explantation of retrievable IVC filters. Three
filters were placed for PE prophylaxis in high-risk patients
prior to elective surgical intervention. Two others were
placed in patients with PE and contraindications to antico-
agulation. All patients had radiographic evidence of cava
penetration by the filter. 4 patients had symptoms attrib-
uted to erosion into adjacent bowel, including one patient
with endoscopic evidence of duodenal penetration. One
patient was asymptomatic but had radiographic evidence of
aortic penetration by a filter leg. All patients had improve-
ment in symptoms and uncomplicated recoveries following
explantation.
Conclusions: This is the largest case series to date
describing the open explantation of IVC filters for IVC
perforation and erosion into adjacent structures. We advo-
cate early endovascular retrieval of IVC filters as soon as PE
risk subsides to avoid long-term complications of retriev-
able IVC filters. In cases of IVC perforation open removal
of IVC filters can be performed safely with minimal risk
when endovascular retrieval is unsuccessful.
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Statin Therapy is Associated with Superior Clinical
Outcomes after Endovascular Treatment of Critical
Limb Ischemia
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Objectives: Statin therapy has been shown to reduce
adverse cardiovascular events in patients with peripheral
artery disease, but their effect on outcomes after lower
extremity endovascular interventions remains uncertain.
The aim of this study was to determine if statin therapy
improves clinical outcomes after endovascular intervention
in patients with critical limb ischemia (CLI).
Methods: A retrospective review of all patients under-
going endovascular treatment for CLI was performed. Pa-
tients were grouped based on whether or not they were
receiving statin therapy at the time of intitial intervention
for CLI. Demographics, lesion type and TASC classifica-
tion as well as overall mortality, primary and secondary
patency and limb salvage were then compared between
these groups. Analysis was performed using multivariate
regression and Kaplan-Meier analysis.
Results: 646 patients (904 limbs) underwent endovas-
cular intervention for CLI between 2004 and 2009. The
statin group had significantly higher rates of diabetes
mellitus, coronary artery disease, congestive heart fail-
ure, previous myocardial infarction and coronary artery
bypass procedure (P0.05). The two groups had similar
lesion characteristics, TASC classification and primary
procedure. At 24 months, the statin-treated group had
higher rates of primary patency (43% vs. 33%; P.007),
secondary patency (66% vs. 51%; P.001), limb salvage
(83% vs. 62%; P.001) and overall survival (77% vs. 62%;
P.038). Statin therapy was also independently associ-
ated with improved limb salvage by multivariate regres-
sion analysis (HR0.315; P.001).
Conclusions: Patients receiving statin therapy at the
time of initial intervention for treatment of CLI had signif-
icantly improved overall survival, primary and secondary
patency and limb salvage rates. Our findings suggest that
statins should be part of the periprocedural treatment reg-
imen for patients undergoing endovascular treatment of
CLI and supports further investigation into the beneficial
effects of statins in CLI.
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